We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

81 hedge funds and large institutions have $105M invested in Calithera Biosciences, Inc in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more call options, than puts

Call options by funds: $494K | Put options by funds: $277K

5% more capital invested

Capital invested by funds: $100M → $105M (+$4.82M)

10% less funds holding

Funds holding: 90 → 81 (-9)

11% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 27

50% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 18

Holders
81
Holders Change
-9
Holders Change %
-10%
% of All Funds
1.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
24
Reduced
27
Closed
18
Calls
$494K
Puts
$277K
Net Calls
+$217K
Net Calls Change
+$402K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$12.1M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$931K
3
JP Morgan Chase
JP Morgan Chase
New York
+$492K
4
Two Sigma Investments
Two Sigma Investments
New York
+$350K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$314K

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.17M
2
American Century Companies
American Century Companies
Missouri
-$2.77M
3
SI
Sofinnova Investments
California
-$1.49M
4
AIM
Alambic Investment Management
California
-$1.01M
5
AC
Ascend Capital
California
-$960K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$401K +$40.7K +427 +13%
AQR Capital Management
27
AQR Capital Management
Connecticut
$395K -$266K -2,796 -43%
Two Sigma Investments
28
Two Sigma Investments
New York
$385K +$350K +3,671 New
Wells Fargo
29
Wells Fargo
California
$372K +$23.7K +249 +8%
BCM
30
Bridgeway Capital Management
Texas
$352K -$354K -3,720 -53%
Charles Schwab
31
Charles Schwab
California
$341K -$19K -200 -6%
AA
32
ALPS Advisors
Colorado
$334K +$55.5K +583 +22%
CAM
33
ClariVest Asset Management
California
$300K -$19.5K -205 -7%
FAM
34
Fred Alger Management
New York
$294K +$200K +2,100 +300%
Millennium Management
35
Millennium Management
New York
$291K -$307K -3,229 -54%
USAA
36
United Services Automobile Association
Texas
$284K -$3.62K -38 -1%
Squarepoint
37
Squarepoint
New York
$279K -$25.7K -270 -9%
T. Rowe Price Associates
38
T. Rowe Price Associates
Maryland
$268K -$70.4K -739 -22%
AIM
39
Alambic Investment Management
California
$267K -$1.01M -10,622 -81%
Acadian Asset Management
40
Acadian Asset Management
Massachusetts
$253K +$31.7K +333 +16%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$249K – – –
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$172K -$105K -1,100 -40%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$167K – – –
AllianceBernstein
44
AllianceBernstein
Tennessee
$160K – – –
AC
45
Ascend Capital
California
$138K -$960K -10,084 -88%
Barclays
46
Barclays
United Kingdom
$125K +$76.6K +804 +205%
Renaissance Technologies
47
Renaissance Technologies
New York
$124K -$657K -6,901 -85%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$121K – – –
Citigroup
49
Citigroup
New York
$119K +$36.1K +379 +50%
PPA
50
Parametric Portfolio Associates
Washington
$117K +$106K +1,116 New
1
2
3 4

CALA Hedge Fund Activity: Q3 2018 in Review

81 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2018, worth a combined $105M — up 4.8% from $100M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CALA and 9 opened new positions — a net loss of 9 holders — while 27 trimmed existing stakes and 24 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $12.1M. The largest seller was Wellington Management Group, cutting an estimated $4.17M.

  • 81 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2018, down from 90 in Q2 2018.
  • Funds reported $105M of Calithera Biosciences, Inc stock for Q3 2018, up 4.8% quarter-over-quarter.
  • 9 funds opened new Calithera Biosciences, Inc positions in Q3 2018 and 18 closed out, a net change of -9 holders.
  • The largest Calithera Biosciences, Inc buyer in Q3 2018 was BVF Inc, an estimated $12.1M added.
  • The largest Calithera Biosciences, Inc seller in Q3 2018 was Wellington Management Group, an estimated $4.17M sold.

Based on aggregated 13F filings for Q3 2018.